VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CPRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CPRXCatalyst Pharmaceuticals, Inc.
$31.49$3.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCPRXQuarterly Financials

Catalyst Pharmaceuticals, Inc. (CPRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Catalyst Pharmaceuticals, Inc. (CPRX) quarterly income statement — complete revenue, gross profit & net income history

CPRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue149.39M152.61M148.39M146.56M141.42M141.82M128.69M122.71M98.51M110.57M102.69M99.58M85.37M60.76M57.24M53.11M43.09M38.31M35.95M36.37M
Revenue Growth %5.63%7.61%15.31%19.44%43.56%28.27%25.33%23.23%15.4%81.98%79.39%87.49%98.12%58.6%59.21%46.06%42.66%23.52%22.64%22.84%
Cost of Goods Sold24.18M26.07M25.31M29.96M17.91M21.64M19.28M15.4M12.52M15.81M14.17M12.04M9.95M11.2M9.66M7.64M5.89M7.35M5.31M4.54M
COGS % of Revenue16.18%17.09%17.06%20.44%12.67%15.26%14.98%12.55%12.71%14.3%13.8%12.1%11.65%18.43%16.88%14.39%13.67%19.18%14.77%12.5%
Gross Profit125.21M126.54M123.08M116.61M123.51M120.18M109.42M107.31M85.99M94.76M88.52M87.54M75.42M49.56M47.58M45.47M37.2M30.96M30.64M31.82M
Gross Margin %83.82%82.92%82.94%79.56%87.33%84.74%85.02%87.45%87.29%85.7%86.2%87.9%88.35%81.57%83.12%85.61%86.33%80.82%85.23%87.5%
Gross Profit Growth %1.38%5.29%12.49%8.67%43.63%26.82%23.61%22.58%14.01%91.19%86.05%92.52%102.75%60.08%55.26%42.9%45.74%18.42%20.47%24.96%
Operating Expenses51.98M64.69M56.81M50.31M60.14M57.33M58.51M53.06M58.86M53.07M125.71M40.84M39.81M18.76M22.48M16.9M19.83M18.22M16.64M15.98M
OpEx % of Revenue34.79%42.39%38.29%34.32%42.53%40.43%45.46%43.24%59.75%47.99%122.42%41.01%46.64%30.88%39.27%31.82%46.03%47.56%46.28%43.95%
Selling, General & Admin49.32M53.42M47.47M45.95M46.91M44.19M45.88M40.73M46.94M42.04M33.56M28.4M29.72M14.67M13.65M12.92M16.43M13.23M12.15M11.53M
SG&A % of Revenue33.01%35%31.99%31.35%33.17%31.16%35.65%33.19%47.65%38.02%32.68%28.52%34.81%24.14%23.84%24.32%38.13%34.53%33.8%31.71%
Research & Development2.66M1.81M2.66M4.36M3.89M3.8M3.28M2.98M2.58M1.97M83.66M3.95M3.56M4.09M8.31M3.98M3.4M4.99M4.49M4.45M
R&D % of Revenue1.78%1.18%1.79%2.97%2.75%2.68%2.55%2.43%2.62%1.78%81.47%3.97%4.17%6.74%14.52%7.5%7.9%13.03%12.48%12.24%
Other Operating Expenses01000K1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K0518K00000
Operating Income73.23M61.85M66.27M66.3M63.37M62.84M50.91M54.25M27.13M41.69M-37.19M46.7M35.61M30.8M25.1M28.57M17.37M12.74M14M15.84M
Operating Margin %49.02%40.52%44.66%45.24%44.81%44.31%39.56%44.21%27.54%37.71%-36.21%46.89%41.71%50.7%43.85%53.79%40.3%33.26%38.95%43.55%
Operating Income Growth %15.57%-1.59%30.17%22.22%133.6%50.73%236.9%16.16%-23.82%35.36%-248.15%63.46%105.05%141.73%79.25%80.38%77.19%47.86%19.65%54.04%
EBITDA83.08M71.38M75.68M75.76M72.83M72.3M50.91M63.68M36.56M50.84M-28.62M55.27M42.21M31.48M25.66M28.61M17.4M12.78M14.04M15.87M
EBITDA Margin %55.61%46.77%51%51.69%51.5%50.98%39.56%51.9%37.11%45.98%-27.87%55.5%49.44%51.81%44.82%53.86%40.38%33.35%39.04%43.64%
EBITDA Growth %14.08%-1.27%48.66%18.96%99.22%42.23%277.88%15.22%-13.39%61.49%-211.56%93.21%142.58%146.41%82.79%80.26%75.79%47.7%19.61%54.85%
D&A (Non-Cash Add-back)9.85M9.54M9.42M9.46M9.46M9.46M09.44M9.43M9.14M8.57M8.57M6.6M678K553K37K34K33K31K31K
EBIT73.23M61.85M71.03M69.29M63.37M62.84M50.91M54.25M27.13M41.69M-37.19M46.7M35.61M33.01M25.1M28.57M17.37M12.74M14M15.84M
Net Interest Income6.25M005.95M5.28M4.62M4.54M3.8M00-265K1.81M00000000
Interest Income6.25M005.95M5.28M4.62M4.54M3.8M0001.81M00000000
Interest Expense0000000000265K000000000
Other Income/Expense11M10.05M4.77M3M7.92M11.34M6.3M1.54M1.96M5.01M-833K1.81M1.7M2.21M905K-324K93K71K68K62K
Pretax Income84.23M71.9M71.03M69.29M71.29M74.18M57.2M55.79M29.09M46.71M-38.02M48.51M37.31M33.01M26.01M28.25M17.46M12.81M14.07M15.9M
Pretax Margin %56.38%47.11%47.87%47.28%50.41%52.31%44.45%45.46%29.53%42.24%-37.03%48.72%43.71%54.33%45.43%53.18%40.52%33.45%39.14%43.72%
Income Tax20.5M19.2M18.25M17.18M14.55M18.25M13.32M14.99M5.81M11.86M-7.26M10.75M7.75M7.54M3.26M6.63M4.22M3.5M3.74M3.72M
Effective Tax Rate %24.33%26.71%25.69%24.8%20.41%24.6%23.29%26.88%19.99%25.4%19.09%22.16%20.76%22.83%12.53%23.46%24.16%27.35%26.6%23.39%
Net Income63.73M52.7M52.78M52.11M56.74M55.94M43.88M40.79M23.27M34.84M-30.76M37.76M29.57M25.47M22.75M21.62M13.24M9.31M10.33M12.18M
Net Margin %42.66%34.53%35.57%35.55%40.12%39.44%34.1%33.24%23.63%31.51%-29.96%37.92%34.64%41.92%39.74%40.7%30.73%24.3%28.73%33.5%
Net Income Growth %12.33%-5.79%20.28%27.73%143.77%60.53%242.65%8.03%-21.28%36.8%-235.24%74.67%123.31%173.62%120.23%77.48%72.79%-18.61%-76.17%24.55%
Net Income (Continuing)63.73M52.7M52.78M52.11M56.74M55.94M43.88M40.79M23.27M34.84M-30.76M37.76M29.57M25.47M22.75M21.62M13.24M9.31M10.33M12.18M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.500.400.420.410.450.440.350.330.190.31-0.290.330.260.220.200.200.120.090.100.11
EPS Growth %11.11%-9.09%20%24.24%136.84%41.94%220.69%0%-26.92%40.91%-245%65%116.67%144.44%100%81.82%71.43%-18.18%-75.61%22.22%
EPS (Basic)0.520.420.430.430.470.470.370.350.200.33-0.290.360.280.240.220.200.120.090.100.12
Diluted Shares Outstanding126.9M127.26M127.09M127.54M126.96M126.28M125.41M124.66M123.4M113.76M106.57M113.67M113.99M113.53M111.99M109.26M109.04M108.96M107.84M107.73M
Basic Shares Outstanding122.25M122.29M122.6M122.16M121.47M119.89M118.93M118.18M116.81M106.71M106.57M106.26M105.56M104.58M103.32M108.09M109.04M103.11M103.2M103.41M
Dividend Payout Ratio--------------------